Evidence map›Paper›PMID 33452764›Full record

ArticleJournal of cellular and molecular medicine2021

Exploring the five different genes associated with PKCα in bladder cancer based on gene expression microarray.

Xiaotong Zhang, Jiarun Zhang, Hao Zhang, Yang Liu, Lei Yin, Xi Liu, Xuejie Li, Xiuyue Yu, Jinlong Yao, Zhe Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Xiaotong ZhangDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Jiarun ZhangDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Hao ZhangDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Yang LiuDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Lei YinDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Xi LiuDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Xuejie LiDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Xiuyue YuDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Jinlong YaoDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Zhe ZhangDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.
Chuize KongDepartment of Urology, The First Hospital of China Medical University, Shenyang, China.ORCID 0000-0002-0875-2173
First Hospital of China Medical University · CN

Funding

China Medical University's 2017 discipline promotion program 2017XK08China Medical University's 2018 Discipline Promotion ProgramLiaoning Natural Science Fund 201602830National Natural Science Fund 81672525Shenyang clinical medicine research center [2017]76Shenyang Plan Project of Science and Technology F17-230-9-08the Project of Liaoning Distinguished Professor [2012]145
6 · The paper itself

Abstract

Much progress has been made in understanding the mechanism of bladder cancer (BC) progression. Protein kinase C-α (PKCα) is overexpressed in many kinds of cancers. Additionally, PKCα is considered an oncogene that regulates proliferation, invasion, migration, apoptosis and cell cycle in multiple cancers. However, the mechanism underlying how these cellular processes are regulated by PKCα remains unknown. In the present study, we used PKCα siRNA to knock down PKCα gene expression and found that down-regulation of PKCα could significantly inhibit cell proliferation, migration and invasion and induce apoptosis and G1/S cell cycle arrest in vitro. Overexpression of PKCα promotes tumour growth in vivo. We applied cDNA microarray technology to detect the differential gene expression in J82 cells with PKCα knockdown and found that five key genes (BIRC2, BIRC3, CDK4, TRAF1 and BMP4) were involved in proliferation and apoptosis according to GO analysis and pathway analyses. Correlation analysis revealed a moderate positive correlation between PKCα expression and the expression of five downstream genes. BIRC2 and BIRC3 inhibit apoptosis, whereas CDK4, TRAF1 and BMP4 promote proliferation. Essentially, all five of these target genes participated in proliferation, and apoptosis was regulated by PKCα via the NF-kB signalling pathway.

Indexed as

Biomarkers, TumorGene Expression Regulation, NeoplasticAgedAged, 80 and overApoptosisCell Line, TumorComputational BiologyFemaleGene Expression ProfilingHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingProtein Kinase C-alphaSignal TransductionBiomarkers, TumorPRKCA protein, humanProtein Kinase C-alphaapoptosisbladder cancermicroarrayNF-kbPKCαproliferation

Identifiers

PMID33452764
PMCPMC7875937
OpenAlexW3124784986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.